4579.T
Price:
$1129
Market Cap:
$27.61B
RaQualia Pharma Inc. engages in the research and development of pharmaceutical compounds worldwide. Its human products portfolio includes tegoprazan for gastroesophageal reflux disease, which is in phase 1 clinical trial in the United States; and grapiprant for pain management, which is in phase II clinical trial in the United States and phase I clinical trial in China, as well as in phase I clinical trial in China and the United States to treat cancer. The company also provides veterinary products such as, grapiprant for osteoarthritis in dogs; ghrelin receptor agonist to treat cancer-related anorexia/cachexia syndrome, and constipation resulting from spinal cord injury; and ELURA, a drug f...[Read more]
Industry
Biotechnology
IPO Date
2011-07-20
Stock Exchange
JPX
Ticker
4579.T
According to RaQualia Pharma Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -48.31. This represents a change of -67.03% compared to the average of -146.54 of the last 4 quarters.
The mean historical PE Ratio of RaQualia Pharma Inc. over the last ten years is 432.02. The current -48.31 PE Ratio has changed -1218.24% with respect to the historical average. Over the past ten years (40 quarters), 4579.T's PE Ratio was at its highest in in the December 2020 quarter at 57.14. The PE Ratio was at its lowest in in the September 2022 quarter at -2353.71.
Average
432.02
Median
-13.50
Minimum
-785.33
Maximum
5.17K
Discovering the peaks and valleys of RaQualia Pharma Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 7.59%
Maximum Annual PE Ratio = 5.17K
Minimum Annual Increase = -26118.40%
Minimum Annual PE Ratio = -785.33
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -16.79 | -63.44% |
| 2023 | -45.93 | -228.60% |
| 2022 | 35.71 | 9.73% |
| 2021 | 32.55 | -194.30% |
| 2020 | -34.52 | -100.67% |
| 2019 | 5.17K | -26118.40% |
| 2018 | -19.86 | -97.47% |
| 2017 | -785.33 | 7.59% |
| 2016 | -10.21 | 253.76% |
| 2015 | -2.89 | -70.03% |
The current PE Ratio of RaQualia Pharma Inc. (4579.T) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-9.00
5-year avg
-5.79
10-year avg
432.02
RaQualia Pharma Inc.’s PE Ratio is less than NANO MRNA Co.,Ltd. (-11.87), less than MediciNova, Inc. (-6.48), less than CellSeed Inc. (-9.03), less than Japan Medical Dynamic Marketing, Inc. (-18.61), less than Kidswell Bio Corporation (32.93), less than CanBas Co., Ltd. (-13.23), greater than Stella Pharma Corporation (-62.87), less than Techno Medica Co., Ltd. (16.82), less than Daiken Medical Co., Ltd. (12.34), less than Chiome Bioscience Inc. (-7.56),
| Company | PE Ratio | Market cap |
|---|---|---|
| -11.87 | $10.48B | |
| -6.48 | $11.53B | |
| -9.03 | $9.36B | |
| -18.61 | $12.46B | |
| 32.93 | $10.76B | |
| -13.23 | $15.57B | |
| -62.87 | $8.54B | |
| 16.82 | $14.26B | |
| 12.34 | $12.64B | |
| -7.56 | $7.55B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RaQualia Pharma Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like RaQualia Pharma Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is RaQualia Pharma Inc.'s PE Ratio?
How is the PE Ratio calculated for RaQualia Pharma Inc. (4579.T)?
What is the highest PE Ratio for RaQualia Pharma Inc. (4579.T)?
What is the 3-year average PE Ratio for RaQualia Pharma Inc. (4579.T)?
What is the 5-year average PE Ratio for RaQualia Pharma Inc. (4579.T)?
How does the current PE Ratio for RaQualia Pharma Inc. (4579.T) compare to its historical average?